Five New Aesthetics Launches Making Headlines in 2026

From regenerative injectables and innovative skin boosters to next-generation devices and advanced skincare technologies, 2026 has already delivered a wave of exciting product launches for aesthetic practitioners. As the industry continues to shift towards skin quality, longevity and regenerative medicine, manufacturers are introducing products designed to enhance natural results while improving long-term skin health.

Here are 5 of the most talked-about launches in aesthetics across the UK and Ireland this year.

Teoxane babyGLOW™

Unveiled at IMCAS 2026 and subsequently launched in the UK and Ireland, babyGLOW™ is Teoxane’s new anatomy-based injection protocol designed to improve skin quality, hydration and radiance. Using strategically selected injection points, the treatment aims to create a brighter, fresher appearance without adding volume or altering facial features.

EMFUSION® by BTL Aesthetics

One of the most talked-about device launches of 2026, EMFUSION® has been positioned as the first aesthetic technology specifically developed around the concept of “skin longevity”. The non-invasive device focuses on supporting skin barrier function, tissue quality and long-term skin health rather than targeting a single ageing concern. Its launch reflects the industry’s growing emphasis on preventative and regenerative approaches to aesthetic medicine, with practitioners increasingly seeking treatments that improve skin resilience and function over time.

Celora™ Vita by DermaFocus

Launched in the UK in March 2026, Celora™ Vita represents DermaFocus’ first proprietary injectable product and introduces a new biorestorative approach to skin rejuvenation. The injectable combines nine amino acids with low molecular weight hyaluronic acid to support extracellular matrix renewal, collagen synthesis and overall skin quality.

Rather than focusing on volumisation, Celora™ Vita has been developed to address substrate depletion within the dermis, making it one of the year’s most notable regenerative aesthetics launches.

Medik8 Exo PDRN Prismatic+ Pro Concentrate

Created for use alongside microneedling or as post-treatment aftercare, the formula can be applied after chemical peels, laser procedures, facials and LED therapy. It combines advanced PDRN technology with regenerative actives to support faster skin recovery and visible rejuvenation.

Clinical testing shows the formula significantly amplifies outcomes when paired with microneedling, delivering results that are five times more powerful than microneedling alone, with marked improvements in wrinkle reduction, firmness and elasticity over a four week period in an independent split-face study of 25 participants.

Evolus Estyme

Estyme is an injectable hyaluronic acid made with Cold-X Technology by Symatese. According to Symatese the technology behind the product makes it possible to develop highly targeted products, each dedicated to an indication of the face.

Each products ESTYME® SMOOTH, LIPS, FORM & SCULPT has specific characteristics and responds exactly and effectively to the needs of the area concerned.

The new injectable product was launched across Europe on May 16th following it’s launched in the US.